Cowin China Growth Fund II, L.P. reduced its holdings in INNOGEN-B (02591) by 2.87 million shares at a price of approximately HKD 3.64 per share.
On September 3, Cowin China Growth Fund II, L.P. reduced its holdings in Silver Mountain Medical-B (02591) by 2.87 million shares, at a price of HKD 3.6397 per share, for a total amount of approximately HKD 10.4459 million.
According to the latest data from the Hong Kong Stock Exchange, on September 3, Cowin China Growth Fund II, L.P. reduced its holdings in INNOGEN-B (02591) by 2.87 million shares, at a price of HKD 3.6397 per share, for a total amount of approximately HKD 10.4459 million. After the reduction, the latest number of shares held is approximately 17.7864 million, with the latest shareholding ratio being 4.23%.
This transaction involves other related parties: Cowin Capital Investment Limited, Cowin Capital Investment II LTD, Cowin Capital Investment III Limited.
Related Articles
Blue Owl Capital (OWL.US) is targeting the IPO surge in AI data centers and plans to package approximately $6.5 billion in assets into a new REIT for listing.
US Stock Market Move | Hello Group Inc. Sponsored ADR (MOMO.US) rose more than 6%, with overseas net revenue in the second quarter increasing by 52% year-on-year.
US Stock Market Move | Sales of Q2 core product yoga pants plummeted 20%, Lululemon Athletica (LULU.US) dropped over 18%.
Blue Owl Capital (OWL.US) is targeting the IPO surge in AI data centers and plans to package approximately $6.5 billion in assets into a new REIT for listing.
US Stock Market Move | Hello Group Inc. Sponsored ADR (MOMO.US) rose more than 6%, with overseas net revenue in the second quarter increasing by 52% year-on-year.
US Stock Market Move | Sales of Q2 core product yoga pants plummeted 20%, Lululemon Athletica (LULU.US) dropped over 18%.
RECOMMEND
